• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 6-芳基甲叉青霉素的砜抑制剂可重新用于提高优先病原体的抗生素效率。

6-Arylmethylidene Penicillin-Based Sulfone Inhibitors for Repurposing Antibiotic Efficiency in Priority Pathogens.

机构信息

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, Jenaro de la Fuente s/n, 15782 Santiago de Compostela, Spain.

Servicio de Microbiología do Complexo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, Spain.

出版信息

J Med Chem. 2020 Apr 9;63(7):3737-3755. doi: 10.1021/acs.jmedchem.0c00127. Epub 2020 Mar 31.

DOI:10.1021/acs.jmedchem.0c00127
PMID:32196336
Abstract

The ability of 6-(aryl)methylidene penicillin-based sulfones - to repurpose β-lactam antibiotics activity with bacterial species that carry carbapenem-hydrolyzing class D β-lactamases (OXA-23, OXA-24/40 and OXA-48), as well as with class A (TEM-1, CTX-M-2) and class C (CMY-2, DHA-1) enzymes, is reported. The combinations imipenem/ and imipenem/ restored almost completely the antibiotic efficacy in OXA-23 and OXA-24/40 carbapenemase-producing strains (1 μg mL) and also provided good results for OXA-48 carbapenemase-producing strains (4 μg mL). Compounds - in combinations with ceftazidime and ampicillin were also efficient in restoring antibiotic efficacy in strains carrying class C (CMY-2 and DHA-1) and class A (TEM-1 and CTX-M-2) β-lactamase enzymes, respectively. Kinetic and inhibition studies with the OXA-24/40 enzyme, protein mass spectrometry analysis and docking studies allowed us to gain an insight into the inhibition mechanism and the experimentally observed differences between the ligands.

摘要

基于 6-(芳基)亚甲基青霉素的砜类化合物能够重新利用β-内酰胺抗生素的活性,这些抗生素可以与携带碳青霉烯水解酶 D 类β-内酰胺酶(OXA-23、OXA-24/40 和 OXA-48)的细菌,以及 A 类(TEM-1、CTX-M-2)和 C 类(CMY-2、DHA-1)酶的细菌结合。研究报道了亚胺培南/和亚胺培南/与 OXA-23 和 OXA-24/40 碳青霉烯酶产生菌(1μg/mL)的组合几乎完全恢复了抗生素的疗效,并且对 OXA-48 碳青霉烯酶产生菌(4μg/mL)也有很好的效果。化合物-与头孢他啶和氨苄西林的组合在携带 C 类(CMY-2 和 DHA-1)和 A 类(TEM-1 和 CTX-M-2)β-内酰胺酶的菌株中也能有效地恢复抗生素的疗效。与 OXA-24/40 酶的动力学和抑制研究、蛋白质质谱分析和对接研究使我们能够深入了解抑制机制和实验观察到的配体之间的差异。

相似文献

1
6-Arylmethylidene Penicillin-Based Sulfone Inhibitors for Repurposing Antibiotic Efficiency in Priority Pathogens.基于 6-芳基甲叉青霉素的砜抑制剂可重新用于提高优先病原体的抗生素效率。
J Med Chem. 2020 Apr 9;63(7):3737-3755. doi: 10.1021/acs.jmedchem.0c00127. Epub 2020 Mar 31.
2
Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.β-内酰胺酶抑制剂 LN-1-255 对鲍曼不动杆菌碳青霉烯水解酶 D 类β-内酰胺酶的活性。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01172-17. Print 2017 Nov.
3
LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48.LN-1-255,一种能够抑制D类碳青霉烯酶OXA-48的青霉烷酸砜。
J Antimicrob Chemother. 2016 Aug;71(8):2171-80. doi: 10.1093/jac/dkw105. Epub 2016 Apr 28.
4
C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Carbapenemase OXA-23 by Impeding Deacylation.C6 羟甲基取代碳青霉烯 MA-1-206 通过阻碍去酰化抑制主要碳青霉烯酶 OXA-23。
mBio. 2022 Jun 28;13(3):e0036722. doi: 10.1128/mbio.00367-22. Epub 2022 Apr 14.
5
In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.2015-2016 年在希腊医院分离的产非 MBL 碳青霉烯酶肺炎克雷伯菌的亚胺培南-雷利巴坦体外活性。
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1143-1150. doi: 10.1007/s10096-019-03517-y. Epub 2019 Mar 1.
6
In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.NXL104(阿维巴坦)联合β-内酰胺类药物对包括产 OXA-48 碳青霉烯酶肺炎克雷伯菌在内的革兰氏阴性菌的体外活性。
Int J Antimicrob Agents. 2012 Jan;39(1):86-9. doi: 10.1016/j.ijantimicag.2011.09.012. Epub 2011 Oct 29.
7
Penicillin sulfone inhibitors of class D beta-lactamases.D 类β-内酰胺酶的青霉素砜抑制剂。
Antimicrob Agents Chemother. 2010 Apr;54(4):1414-24. doi: 10.1128/AAC.00743-09. Epub 2010 Jan 19.
8
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.WCK 4234是一种新型二氮杂双环辛烷,可增强碳青霉烯类药物对具有A类、C类和D类β-内酰胺酶的肠杆菌科细菌、铜绿假单胞菌和不动杆菌的抗菌活性。
J Antimicrob Chemother. 2017 Jun 1;72(6):1688-1695. doi: 10.1093/jac/dkx035.
9
Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.LN-1-255 联合亚胺培南治疗耐碳青霉烯类鲍曼不动杆菌引起的严重感染的疗效。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01092-19. Print 2019 Oct.
10
Structural studies on New Delhi Metallo-β-lactamase (NDM-2) suggest old β-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni.结构研究表明,新德里金属β-内酰胺酶(NDM-2)暗示老的β-内酰胺类抗生素青霉素可能是携带 NDM-2 的鲍曼不动杆菌更好的抗生素。
J Biomol Struct Dyn. 2013;31(6):591-601. doi: 10.1080/07391102.2012.706075. Epub 2012 Aug 13.

引用本文的文献

1
Synthesis of Thieno[2,3-c]pyridine Derivatives by 1,2,3-Triazole-Mediated Metal-Free Denitrogenative Transformation Reaction.通过1,2,3-三唑介导的无金属脱氮转化反应合成噻吩并[2,3-c]吡啶衍生物
ChemistryOpen. 2025 May;14(5):e202500060. doi: 10.1002/open.202500060. Epub 2025 Mar 15.
2
Characterization of acquired β-lactamases in and quantification of their contributions to resistance.研究获得性β-内酰胺酶的特性及其对耐药性的贡献。
Microbiol Spectr. 2024 Oct 3;12(10):e0069424. doi: 10.1128/spectrum.00694-24. Epub 2024 Sep 9.
3
Novel Penicillin-Based Sulfone-Siderophore Conjugates for Restoring β-Lactam Antibiotic Efficacy.
用于恢复β-内酰胺抗生素疗效的新型基于青霉素的砜-铁载体缀合物
ACS Omega. 2024 May 28;9(24):26484-26494. doi: 10.1021/acsomega.4c02984. eCollection 2024 Jun 18.
4
Carbapenemase Inhibitors: Updates on Developments in 2021.碳青霉烯酶抑制剂:2021年研究进展更新
J Clin Med Res. 2022 Jul;14(7):251-259. doi: 10.14740/jocmr4764. Epub 2022 Jul 29.
5
β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources.β-内酰胺类抗生素与β-内酰胺酶抑制剂,第二部分:我们有限的资源
Pharmaceuticals (Basel). 2022 Apr 13;15(4):476. doi: 10.3390/ph15040476.
6
Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production.合成新旧β-内酰胺酶抑制剂的建议:鼓励进一步生产的综述
Pharmaceuticals (Basel). 2022 Mar 21;15(3):384. doi: 10.3390/ph15030384.
7
β-lactam Resistance in : Current Status, Future Prospects.β-内酰胺类抗生素耐药性:现状与未来展望
Pathogens. 2021 Dec 18;10(12):1638. doi: 10.3390/pathogens10121638.
8
Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against spp.亚胺培南、美罗培南、头孢吡肟和舒巴坦与β-内酰胺酶抑制剂LN-1-255联合对[具体菌种]的活性
Antibiotics (Basel). 2021 Feb 20;10(2):210. doi: 10.3390/antibiotics10020210.
9
New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams.新型碳青霉烯酶抑制剂:为β-内酰胺类药物开辟道路。
Int J Mol Sci. 2020 Dec 6;21(23):9308. doi: 10.3390/ijms21239308.